Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richman

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transferC M Gomez, D P Richman, S A Burres, et al.
Journal of Hepatocellular Carcinoma|February 3, 2018
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinomaLynn G Feun, Medhi Wangpaichitr, Ying-Ying Li, et al.
The British Journal of Cancer. Supplement|July 1, 1990
99mTc radioimmunoscintigraphy of colorectal cancerM Granowska, S J Mather, K E Britton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancerT M Woodcock, M S Blumenreich, S P Richman, et al.
Annals of the New York Academy of Sciences|December 21, 2012
Animal models of antimuscle-specific kinase myastheniaDavid P Richman, Kayoko Nishi, Michael J Ferns, et al.
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanomaS P Richman, T M Woodcock, T T Kubota, et al.
Nature|August 14, 1980
Monoclonal anti-acetylcholine receptor antibodies can cause experimental myastheniaD P Richman, C M Gomez, P W Berman, et al.
Biochemical and Biophysical Research Communications|May 28, 1979
Monoclonal antibodies against purified nicotinic acetylcholine receptorC M Gomez, D P Richman, P W Berman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease ProphylaxisAustin P Huffman, Lee P Richman, Lisa Crisalli, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transferC M Gomez, D P Richman, S A Burres, et al.
Journal of Hepatocellular Carcinoma|February 3, 2018
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinomaLynn G Feun, Medhi Wangpaichitr, Ying-Ying Li, et al.
The British Journal of Cancer. Supplement|July 1, 1990
99mTc radioimmunoscintigraphy of colorectal cancerM Granowska, S J Mather, K E Britton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancerT M Woodcock, M S Blumenreich, S P Richman, et al.
Annals of the New York Academy of Sciences|December 21, 2012
Animal models of antimuscle-specific kinase myastheniaDavid P Richman, Kayoko Nishi, Michael J Ferns, et al.
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanomaS P Richman, T M Woodcock, T T Kubota, et al.
Nature|August 14, 1980
Monoclonal anti-acetylcholine receptor antibodies can cause experimental myastheniaD P Richman, C M Gomez, P W Berman, et al.
Biochemical and Biophysical Research Communications|May 28, 1979
Monoclonal antibodies against purified nicotinic acetylcholine receptorC M Gomez, D P Richman, P W Berman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease ProphylaxisAustin P Huffman, Lee P Richman, Lisa Crisalli, et al.
Pageof 21